发布求助
文献互助 智能选刊 最新文献

Journal of Cardiology & Current Research最新文献

筛选
英文 中文
Anticoagulation with Edoxaban in COVID-19 patients 新冠肺炎患者应用依多沙班抗凝治疗
Journal of Cardiology & Current Research Pub Date : 2021-07-08 DOI: 10.15406/jccr.2021.14.00519
G. Fazio, taffiere Elio, L. Gianturco, L. D. Diodoro, S. Pipitone, Emanuele Verghi, P. Colonna, M. Volterrani, Gabriele Catena
{"title":"Anticoagulation with Edoxaban in COVID-19 patients","authors":"G. Fazio, taffiere Elio, L. Gianturco, L. D. Diodoro, S. Pipitone, Emanuele Verghi, P. Colonna, M. Volterrani, Gabriele Catena","doi":"10.15406/jccr.2021.14.00519","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00519","url":null,"abstract":"","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85609568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New devices for diagnosis of atrial fibrillation: is necessary to treat with oral anticoagulation all patients? 房颤诊断新装置:是否有必要对所有患者进行口服抗凝治疗?
Journal of Cardiology & Current Research Pub Date : 2021-07-06 DOI: 10.15406/jccr.2021.14.00516
G. Fazio, Randazzo Natale Eliseo
{"title":"New devices for diagnosis of atrial fibrillation: is necessary to treat with oral anticoagulation all patients?","authors":"G. Fazio, Randazzo Natale Eliseo","doi":"10.15406/jccr.2021.14.00516","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00516","url":null,"abstract":"The technical possibility to diagnosis of Atrial Fibrillation is progressive ameliorate, and the number of asymptomatic patients affected by Atrial Fibrillation is increasing. For long time the ECG performed in patient with palpitation or stroke was the unique possibility to obtain a diagnosis of atrial fibrillation. For this reason a secondary Stroke was frequently in previously asymptomatic patients. A lot of patients that we consider “Asymptomatic patients” were been recognized only by cardiac Holler. exam unfrequently were present short episodes of atrial fibrillation. increased to 84%.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85382464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of microRNA in atrial fibrillation: What are the implications for gene therapy? microRNA在房颤中的作用:基因治疗的意义是什么?
Journal of Cardiology & Current Research Pub Date : 2021-06-28 DOI: 10.15406/jccr.2021.14.00513
O. Centurión
{"title":"Role of microRNA in atrial fibrillation: What are the implications for gene therapy?","authors":"O. Centurión","doi":"10.15406/jccr.2021.14.00513","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00513","url":null,"abstract":"The utilization of targeted genetic abnormalities to personalize AF therapy is a compelling approach in current era of efforts to individualize the best therapeutic option for a certain patient. There are certain advantages and disadvantages in the implementation of gene therapy for AF.10–12 Some advantages comprise the fact that is tissue specific with fewer side effects. Due to the fact that the AF substrate is not homogeneous, the efficacy of a single genetic alteration may decrease, and it may preclude the simplicity of the procedure.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77772529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of back pain: sapho syndrome 一个罕见的病例背部疼痛:sapho综合征
Journal of Cardiology & Current Research Pub Date : 2021-06-24 DOI: 10.15406/jccr.2021.14.00512
R. G. Gandhi, L. Boppana, Sravani Lokineni, Megha Garg
{"title":"A rare case of back pain: sapho syndrome","authors":"R. G. Gandhi, L. Boppana, Sravani Lokineni, Megha Garg","doi":"10.15406/jccr.2021.14.00512","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00512","url":null,"abstract":"Back pain is one of the most common reasons for outpatient visits but is rarely severe enough to require hospitalization. Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a chronic inflammatory disorder is one of the rare causes of back pain which occurs in combination with skin symptoms. Here, we present a case of SAPHO syndrome in a 39-year-old man who presented with osteoarticular and dermatologic manifestations.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85739357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low burden atrial fibrillation and iron deficiency anemia as a contributing factor of thromboembolic events 低负荷心房颤动和缺铁性贫血是血栓栓塞事件的一个促成因素
Journal of Cardiology & Current Research Pub Date : 2021-06-15 DOI: 10.15406/jccr.2021.14.00511
Vassilara Foula, Papadopoulos Ioannis, Pipilis Athanasios, Plomaritoglou Androniki, Pothitos George, Spiridaki Aikaterini
{"title":"Low burden atrial fibrillation and iron deficiency anemia as a contributing factor of thromboembolic events","authors":"Vassilara Foula, Papadopoulos Ioannis, Pipilis Athanasios, Plomaritoglou Androniki, Pothitos George, Spiridaki Aikaterini","doi":"10.15406/jccr.2021.14.00511","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00511","url":null,"abstract":"homocysteine levels, transglutaminase antibodies, prothrombin and partial prothrombin levels were within normal ranges, and the prothrombin gene variant G20210 and Factor V Leiden mutations were not detected.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78309404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure in patients with high homocysteine levels 高同型半胱氨酸水平患者的心力衰竭
Journal of Cardiology & Current Research Pub Date : 2021-05-20 DOI: 10.15406/jccr.2021.14.00509
F. Cacciapuoti, Fulvio Cacciapuoti
{"title":"Heart failure in patients with high homocysteine levels","authors":"F. Cacciapuoti, Fulvio Cacciapuoti","doi":"10.15406/jccr.2021.14.00509","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00509","url":null,"abstract":"S-adenosyl-methionine; methyl group; S-adenosyl-homocysteine; S-adenosyl homocysteine Abstract Increased levels of homocysteine (HHcy) can induce both systolic and diastolic left ventricular (LV) dysfunction that may evolve until chronic heart failure (HF). It is known that HHcy acts as an independent risk factor for atherosclerosis and hypercoagulation. This condition may cause coronary artery disease (CAD. Chronic reduction of oxygen supply to the myocardium can induce a reduction in LV contractility. These conditions can further evolve towards HF with reduced ejection fraction (HFrEF). But, HHcy can be also responsible for adverse cardiac remodeling for accumulation and proliferation of interstitial collagen, increased fibrosis and myocardial stiffness and preserved LV ejection fraction (HFpEF). Both HF can be further favoured by the advanced age, hypertension, diabetes and others. The administration of some nutrients, such as folic acid and B 12 vitamin can delay or avoid these cardiac complications. However, the cellular mechanisms behind the adverse effects of Hcy on cardiac remodeling and pump function are not understood.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81550398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin resistance and its metabolic, lipid and cardiovascular consequences 胰岛素抵抗及其代谢、脂质和心血管后果
Journal of Cardiology & Current Research Pub Date : 2021-05-03 DOI: 10.15406/jccr.2021.14.00508
T. L. Martinez, Sidney Carvalho Fernandes, A. Saldanha, A. Margeotto, A. Gasparoto, J. Aldrighi, Marco Antonio De Vivo Barros
{"title":"Insulin resistance and its metabolic, lipid and cardiovascular consequences","authors":"T. L. Martinez, Sidney Carvalho Fernandes, A. Saldanha, A. Margeotto, A. Gasparoto, J. Aldrighi, Marco Antonio De Vivo Barros","doi":"10.15406/jccr.2021.14.00508","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00508","url":null,"abstract":"Many research groups on atherosclerosis have sought through prospective large-scale epidemiological studies to better understand which residual factors would be associated with cardiovascular risk. Thus, atherogenic dyslipidemia was defined, such as the presence in an individual of decreased HDL-C levels, increased triglyceride levels, and a relatively high proportion of small and dense LDL-C particles. On the other hand, it was found that atherogenic dyslipidemia is present in cases of insulin resistance and metabolic syndrome (low HDL-C and elevated triglycerides are part of the definition of this syndrome) and consequently in patients with type 2 diabetes mellitus. Regarding treatment, there are studies in diabetic patients with risk reduction with fenofibrate, and the guidelines recommend the association of fenofibrate with statins. Diabetes mellitus is also an important cause of hospitalizations and proportional mortality, also assuming that most deaths register only the immediate cause of this death, which is often the result of diabetes complications. Most of these complications are cardiovascular diseases, which may manifest as coronary heart disease, cerebrovascular disease or peripheral arteriopathies. These are the so-called macrovascular complications of type 2 diabetes and are present even before the onset of hyperglycemia, due to the presence of insulin resistance and associated metabolic syndrome. Metabolic syndrome is characterized by the presence in the patient of at least 3 out of 5 parameters (increased abdominal waist, high glycemia, hypertriglyceridemia, low HDL-C and arterial hypertension) and is one of the factors responsible for the macrovascular changes.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85362204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversing coronary artery calcium using a functional medicine protocol 使用功能医学方案逆转冠状动脉钙化
Journal of Cardiology & Current Research Pub Date : 2021-04-22 DOI: 10.15406/jccr.2021.14.00506
M. Moran
{"title":"Reversing coronary artery calcium using a functional medicine protocol","authors":"M. Moran","doi":"10.15406/jccr.2021.14.00506","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00506","url":null,"abstract":"Introduction: Coronary artery disease (CAD) is the leading cause of early mortality in Western countries. Coronary artery calcium (CAC) is a reliable study to predict future myocardial events and offers independent cardiac risk information. Standard CAD medications, statins, do not reverse CAC. CAD is a chronic disease mainly caused by chronic inflammation. Reversing or partially reversing CAC using a functional approach, without any prescription medications, is theoretically possible due to the chronic inflammatory nature of CAD. Diagnosis: Diagnosis and follow-up of CAC can be easily performed with CT imaging. Interventions: A baseline cardiac scan was performed, and the presence of mild CAC was confirmed in a 60-year-old male. A functional approach, without any prescription medications, was started a few months later and continued for 12 months. A repeat CT scan performed at this time, showed a significant CAC improvement. Conclusion: A twelve-month functional approach, without prescription medications, successfully decreased CAC.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74085815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of percutaneous reperfusion on ischemic mitral regurgitation in patients presented with inferior ST-segment elevation myocardial infarction 经皮再灌注对下st段抬高型心肌梗死患者缺血性二尖瓣返流的影响
Journal of Cardiology & Current Research Pub Date : 2021-02-28 DOI: 10.15406/JCCR.2021.14.00502
Mahmoud A. Abouomar, Osama Shouib, Timoor Hassan, A. Elsheikh
{"title":"Impact of percutaneous reperfusion on ischemic mitral regurgitation in patients presented with inferior ST-segment elevation myocardial infarction","authors":"Mahmoud A. Abouomar, Osama Shouib, Timoor Hassan, A. Elsheikh","doi":"10.15406/JCCR.2021.14.00502","DOIUrl":"https://doi.org/10.15406/JCCR.2021.14.00502","url":null,"abstract":"Abbreviations: ACS, acute coronary syndrome; AMI, acute myocardial infarction; CAD, coronary artery disease; CBC, complete blood count; CK-MB, creatine kinase–myocardial band; DES, drug eluting stent; DM, diabetes mellitus; EF, ejection fraction; FH, family history; LCX, left circumflex; LV, left ventricle; LVED, left ventricle end diastolic; LVES, left ventricle end systolic; IMR, ischemic mitral regurgitation; MACEs, major adverse cardiac and cerebral events; MR, mitral regurgitation; PCI, percutaneous coronary artery intervention; RCA, right coronary artery; STEMI, ST elevation myocardial infarction; TIA, transient ischemic attack; TO, total occlusion","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"180 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75069780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intra-arrest thrombolysis in pulmonary thromboembolia with a successful clinical and neurological outcome: a case report 肺血栓栓塞的停搏内溶栓具有成功的临床和神经学结果:1例报告
Journal of Cardiology & Current Research Pub Date : 2021-02-25 DOI: 10.15406/jccr.2021.14.00501
Mateo Zuluaga Gómez, Diego Fernando Abreo Leal, Andrés Felipe Estrada Atehortúa, Juan Pablo Muñoz Rengifo
{"title":"Intra-arrest thrombolysis in pulmonary thromboembolia with a successful clinical and neurological outcome: a case report","authors":"Mateo Zuluaga Gómez, Diego Fernando Abreo Leal, Andrés Felipe Estrada Atehortúa, Juan Pablo Muñoz Rengifo","doi":"10.15406/jccr.2021.14.00501","DOIUrl":"https://doi.org/10.15406/jccr.2021.14.00501","url":null,"abstract":"Pulmonary thromboembolism is a highly fatal entity, and usually presents atypically. Between 80 and 90% of cases of cardiorespiratory arrest secondary to pulmonary embolism occur between 1 and 3hours after the onset of symptoms, requiring a high degree of clinical suspicion as patient management and prognosis will depend on this. We present the case of a 72-year-old man, admitted after gastrointestinal symptoms and syncope, and who presented cardiorespiratory arrest while in the emergency room. Prior to the circulatory arrest, signs of right ventricular dysfunction and intracavitary thrombi were documented, so systemic thrombolysis was administered overall during resuscitation maneuvers. Subsequently the patient evolved successfully with no cardiac or neurological dysfunction.","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80479855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信